EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Galectin-4 and Charcot-Leyden Crystal Protein/Galectin-10 as Emerging Biomarkers of Metabolically Induced Inflammation in Patients with Psoriasis

Anna Baran iD, Julia Nowowiejska iD, Julia Parzych iD, Justyna Magdalena Hermanowicz iD, Beata Sieklucka, Dariusz Pawlak iD, Iwona Flisiak iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna Baran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland. Hauptthemen laut MEDLINE: Galectins, Psoriasis, Galectin 4, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Białystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a complex inflammatory disease related to cardiometabolic disorders (CMDs). Galectin-4 (gal-4) is involved in biological processes such as lipid raft stabilization, intestinal inflammation and tumorigenesis. Charcot-Leyden crystals (CLCs), inter alia, Charcot-Leyden crystal/galectin-10 (CLC/gal-10), are involved in eosinophil-derived diseases. To date, neither of these galectins has been investigated in the context of psoriasis. The study aimed to evaluate serum galectin-4 and -10 levels in psoriatic patients and explore potential relationships with disease activity, metabolic or inflammatory indices. Blood samples were collected from 60 patients with plaque-type psoriasis and 30 healthy volunteers and evaluated using an Enzyme-Linked Immunosorbent Assay (ELISA). Morphological and biochemical indices were measured using routine laboratory techniques. Plasma gal-4 and gal-10 concentrations were significantly higher in patients with psoriasis than in the control group (p < 0.05). Galectins did not correlate with the Psoriasis Area Severity Index (PASI) nor age (p > 0.5); however, gal-4 showed a significant positive correlation with Body Mass Index (BMI), psoriasis duration (p = 0.03), and transaminase activity. Both proteins were the highest in obese psoriatics (p < 0.05). The results indicate that galectin-4 and galectin-10 may be involved in the pathophysiological mechanisms underlying CMDs in psoriatics. These galectins represent promising candidates for biomarkers of metabolically driven inflammation, with galectin-4, in particular, emerging as a potential indicator of hepatic dysfunction in psoriatic patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalectinsPsoriasisGalectin 4InflammationGlycoproteinsCysteine EndopeptidasesHumansBiomarkersFemaleMaleMiddle AgedAdultCase-Control StudiesLysophospholipase

Stichwörter der Autor:innen

Charcot-Leyden crystal proteinatherosclerosiscomorbiditiesgalectin 10galectin 4metabolic syndromepsoriasissystemic therapy

Substanzen

GalectinsBiomarkersGalectin 4galectin 10, humanGlycoproteinslysolecithin acylhydrolaseCysteine EndopeptidasesLysophospholipase

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland.
  • Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C St., 15-089 Bialystok, Poland.

ORCID-Profile: Anna Baran, Julia Nowowiejska, Julia Parzych, Justyna Magdalena Hermanowicz, Dariusz Pawlak, Iwona Flisiak

Förderung

  • Medical University of Białystok

Zitieren

APA

Baran, A., Nowowiejska, J., Parzych, J., Hermanowicz, J. M., Sieklucka, B., Pawlak, D., & Flisiak, I. (2025). Plasma Galectin-4 and Charcot-Leyden Crystal Protein/Galectin-10 as Emerging Biomarkers of Metabolically Induced Inflammation in Patients with Psoriasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110339

Vancouver

Baran A, Nowowiejska J, Parzych J, Hermanowicz JM, Sieklucka B, Pawlak D, et al. Plasma Galectin-4 and Charcot-Leyden Crystal Protein/Galectin-10 as Emerging Biomarkers of Metabolically Induced Inflammation in Patients with Psoriasis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110339

BibTeX
@article{Baran2025,
  author = {Baran, Anna and Nowowiejska, Julia and Parzych, Julia and Hermanowicz, Justyna Magdalena and Sieklucka, Beata and Pawlak, Dariusz and Flisiak, Iwona},
  title = {Plasma Galectin-4 and Charcot-Leyden Crystal Protein/Galectin-10 as Emerging Biomarkers of Metabolically Induced Inflammation in Patients with Psoriasis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110339}
}
Kostenlos starten →